Kestenberg-Messina Kaitlin M. bought ADMA

March 9, 2026 · Form 4 insider transaction

Kestenberg-Messina Kaitlin M. bought 2,500 shares of ADMA Biologics, Inc. at $5.00 per share, a transaction worth $12.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
2,500
Price
$5.00
Total value
$12.5K
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 9, 2026
Filing dateMarch 10, 2026
Shares owned after469,100
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR